Windtree Therapeutics, Inc. announced that it has appointed Daniel Geffken to the company's Board of Directors, effective April 24, 2019. Since 2011, Mr. Geffken has been serving as the Founding Managing Partner of Danforth Advisors. Mr. Geffken will serve as Chairman of the Board's Audit Committee and as a member of the Compensation Committee.